CIRX · Cirtran Corp
Substantial doubt about the company's ability to continue as a going concern.
“As of June 30, 2026, the Company had cash of $158,137, a working capital deficit of approximately $20.3 million, and an accumulated deficit of approximately $60.2 million. In addition, the Company incurred a loss from continuing operations of approximately $161,000 for the six months ended June 30, 2026. These conditions raise substantial doubt about the Company's ability to continue as a going concern within one year after the date the financial statements are issued.”View the 10-Q filed Aug 18, 2026
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Chart any reported metric, KPI or segment over time — the full statement history lives here
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $4.83M | $3.13M | $1.3M | $1.62M | $1.72M | $2.92M | $1.73M | — | — | $12.5K | $3.47M | $4.26M | $3.06M | $9.04M | |
| $2.56M | $1.59M | $458.16K | $609.65K | $696.55K | $1.02M | $896.27K | — | — | — | $1.12M | $375.76K | $1.12M | -$3.65M | |
| $2.27M | $1.54M | $838.64K | $1.01M | $1.02M | $1.9M | $836.35K | — | — | $12.5K | $2.31M | $3.27M | -$196.85K | $3.14M | |
| — | 49.27% | 64.67% | 62.28% | 59.49% | 64.96% | 48.27% | — | — | 100% | 66.65% | 76.75% | -6.42% | 34.73% | |
| $1.45M | $1.16M | $873.57K | $509.9K | $1M | $1.63M | $465.52K | $280.83K | $447.39K | $805.69K | $3.29M | $3.61M | $6.25M | $5.74M | |
| — | — | — | — | — | — | — | — | — | — | $0 | $0 | $26.54K | — | |
| $1955 | $1800 | $4340 | $4507 | $3881 | $3198 | $373 | — | — | — | $46.18K | $86.45K | $189.61K | $653.62K | |
| $1.96M | $1.67M | $1.39M | $1.02M | $1.55M | $2.13M | $757.94K | $406.56K | $447.39K | $805.69K | $3.33M | $3.65M | $6.38M | $6.11M | |
| $303.56K | -$129.72K | -$550.74K | -$14.92K | -$522.28K | -$227.99K | $78.41K | -$406.56K | -$447.39K | -$793.19K | -$1.02M | -$375.81K | -$6.58M | -$2.97M | |
| — | -4.15% | -42.47% | -0.92% | -30.38% | -7.8% | 4.53% | — | — | -6345.55% | -29.27% | -8.82% | -214.57% | -32.86% | |
| $305.51K | -$127.92K | -$546.4K | -$10.41K | -$518.4K | -$224.79K | $78.79K | — | — | — | -$969.14K | -$289.37K | -$6.39M | -$2.32M | |
| $843.51K | $822.74K | $790.59K | $768.9K | $709.41K | $680.43K | $658.65K | $592.76K | $498.78K | $489.06K | — | — | — | — | |
| -$380.22K | -$418.45K | -$2M | -$536.78K | -$775.45K | -$610.49K | $374.22K | -$672.42K | -$498.78K | -$997.51K | $2.24M | -$1.41M | -$468.19K | -$1.98M | |
| $2.12M | -$701.63K | -$2.7M | $20.28M | -$1.45M | $126.21K | — | — | — | — | — | — | — | — | |
| — | — | -$74.36K | -$8533 | $50.89K | — | — | — | — | — | — | — | — | — | |
| $2.13M | -$701.63K | -$2.63M | $20.29M | -$1.5M | $126.21K | $532.13K | -$1.23M | -$1.11M | -$2.05M | $855.91K | -$247.63K | -$6.3M | -$2.62M | |
| — | -22.44% | -202.57% | 1255.35% | -87.36% | 4.32% | 30.71% | — | — | -16398.9% | 24.67% | -5.81% | -205.49% | -28.94% | |
| -$511.7K | — | — | — | — | — | — | — | — | — | $368.34K | -$1.54M | -$746.15K | -$2.34M | |
| USD/shares | $0.44 | -$0.14 | -$0.53 | $4.10 | -$0.30 | $0.03 | $0.12 | -$0.27 | — | — | — | — | — | — |
| USD/shares | $0.44 | -$0.14 | -$0.53 | $4.10 | -$0.30 | $0.00 | $0.00 | -$0.27 | — | — | — | — | — | — |
| shares | — | 4.95M | 4.95M | 4.95M | 4.95M | 4.89M | 4.56M | 4.5M | 4.5M | 4.49B | 4.39B | 1.93B | 1.59B | 1.5B |
| shares | — | 4.95M | 4.95M | 4.95M | 4.95M | 144.26M | 172.32M | 4.5M | 4.5M | 4.49B | 7.64B | 1.93B | 1.59B | 1.5B |
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2025 | FY2024 |
|---|---|---|
| Tobacco Line | $2,937,687 | $1,056,862 |
| All Other Product Line | $189,204 | $239,934 |
By Product & Service (USD)
| Component | FY2024 | FY2023 |
|---|---|---|
| Product Development Service | $90,929 | $410,000 |
Segment Operating Income
Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.
By Segment (USD)
| Component | FY2025 | FY2024 |
|---|---|---|
| All Other Product Line | $63,376 | -$100,712 |
| Tobacco Line | -$193,099 | -$450,027 |
Operating Margin by Segment (%)
| Component | FY2025 | FY2024 |
|---|---|---|
| Tobacco Line | -6.6% | -42.6% |
| All Other Product Line | 33.5% | -42% |